SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-021933
Filing Date
2021-09-03
Accepted
2021-09-03 08:53:39
Documents
19
Period of Report
2021-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42059
2 ex1-1.htm EX-1.1 276749
3 ex5-1.htm EX-5.1 22151
4 ex5-2.htm EX-5.2 35501
5 ex5-1_001.jpg GRAPHIC 3113
6 ex5-1_002.jpg GRAPHIC 5407
7 ex5-2_001.jpg GRAPHIC 3113
8 ex5-2_002.jpg GRAPHIC 5407
  Complete submission text file 0001493152-21-021933.txt   646631

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vbiv-20210903.xsd EX-101.SCH 3033
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vbiv-20210903_lab.xml EX-101.LAB 34239
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vbiv-20210903_pre.xml EX-101.PRE 22364
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3589
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 211235217
SIC: 2834 Pharmaceutical Preparations